# To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension

> **NCT00944489** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1150 (actual)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00944489
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1150 (ACTUAL)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944489, "To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00944489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*